COVID-19:
Temporary Framework for assessing antitrust issues
On
8 April 2020, the European Commission published a Temporary Framework for
assessing antitrust issues in urgent business cooperation situations arising from
the 2019 coronavirus (COVID-19) outbreak.
The
Commission has set up a temporary process to provide, where appropriate, ad hoc
written comfort letters to undertakings in relation to specific and
well-defined cooperation projects.
The
procedure is reminiscent of the pre-2004 practice where the Commission issued administrative
letters to companies indicating that it saw no grounds for action in relation
to a notified agreement.
The
Commission has already applied this procedure and is issuing a comfort letter
to “Medicines for Europe”, formerly the “European Generics Medicines
Association”. The cooperation project
among pharmaceutical producers targets the risk of shortage of critical
hospital medicines.
https://ec.europa.eu/commission/presscorner/detail/en/ip_20_618
No comments:
Post a Comment